Company / Revenue
FENNEC PHARMACEUTICALS INC. Revenue History
FY2014-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue
$47.5M
FY2025
5-year range
$0 / $47.5M
FY2021-FY2025
Trend
+123.7%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Revenue has increased for 4 consecutive years, from $0 in FY2019 to $48M in FY2025.
Based on SEC 10-K filings.
$48M in FY2025.
Improved from $2M to $48M over the past 2 years.
Revenue over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- FENNEC PHARMACEUTICALS INC.'s revenue has grown for 3 consecutive years.
- In FY2025, revenue increased 123.7% year-over-year.
- Lowest revenue in the period was in FY2019.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $47.5M | +123.7% |
| FY2024 | $21.3M | +1284.5% |
| FY2023 | $1.5M | +802.9% |
| FY2021 | $170.0K | - |
| FY2019 | $0 | - |
| FY2018 | $0 | - |
| FY2017 | $0 | - |
| FY2016 | $0 | - |
| FY2015 | $0 | - |
| FY2014 | $0 | - |
As of FY2025 · SEC 10-K Annual Filings · Updated Jun 24, 2026